Trial Information
Quality of Life in Women Surviving Ovarian Cancer
Inclusion Criteria:
- Women with invasive epithelial ovarian cancer who are disease-free and 5 to 10 years
from diagnosis (for Cohort A) and have never experienced a recurrence of epithelial
ovarian cancer
- Women with epithelial ovarian cancer who have had one or more relapses, but are
clinically currently disease-free, 5- to 10 years from diagnosis (for Cohort B)
- Women with current evidence of epithelial ovarian cancer who are alive with disease 5
to 10 years from diagnosis (for Cohort C)
- Fluency in English
- Written informed consent
Exclusion Criteria:
- Inability to read, communicate in English
- ovarian cancer of low malignant potential (borderline tumors)
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
QOL, phys funct status score on FACT & ,psychol status , cognitive functioning, Brief test of Attention, sexual funct & health behaviors among ovar ca survi & among women in 2nd or > remiss & among women surv with ovar ca 5 to 10 yrs from dx.
Outcome Time Frame:
conclusion of study
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
04-131
NCT ID:
NCT00596349
Start Date:
November 2004
Completion Date:
February 2009
Related Keywords:
- Epithelial Ovarian Cancer
- Quality of Life
- Survivorship
- epithelial Ovarian Cancer
- Quality of Life
- Survivorship
- Ovarian Neoplasms
- Neoplasms, Glandular and Epithelial
Name | Location |
Memorial Sloan Kettering Cancer Center |
New York, New York 10021 |